EyePoint Pharmaceuticals renamed to EyePoint, Inc. effective Dec 8, 2025

EyePoint, Inc.

Corporate name changed to EyePoint, Inc.; no change to ticker symbol EYPT.
Name change effective December 8, 2025; CUSIP remains 30233G209.
Stockholder rights unaffected; common stock continues on Nasdaq under EYPT.
No other amendments to certificate or by-laws beside the name change.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

EyePoint, Inc.: On December 8, 2025, the Company filed a certificate of amendment to its Certificate of Incorporation to change its name from 'EyePoint Pharmaceuticals, Inc.' to 'EyePoint, Inc.', effective December 8, 2025 (effective 2025-12-08).

Change: charter amendment
Effective: 2025-12-08

Exact text from the filing

On December 8, 2025, EyePoint, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, as amended, solely to change the Company’s name from “EyePoint Pharmaceuticals, Inc.” to “EyePoint, Inc.” The name change became effective on December 8, 2025.

View on SEC.gov

259 governance changes filed in the last 30 days. Browse all governance changes →

EyePoint, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-310731

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.